Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Are you Dr. Cascone?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tina Cascone, MD is a hematologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Alabama, and Arizona.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2012 - 2014
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2016 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target.Giannis Mountzios, Stephanie P L Saw, Lizza Hendriks, Jessica Menis, Tina Cascone
Cancer Treatment Reviews. 2025-03-01 - 1 citationsAuthor Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2025-03-01 - A Roadmap to Precision Immunotherapy for Early-Stage Non-Small Cell Lung Cancer.Alessandra Vaccaro, Zahraa Rahal, Humam Kadara, Tina Cascone
Cancer Discovery. 2025-02-25
Press Mentions
11 New Research Advances from the Past YearDecember 19th, 2024- MD Anderson Research Highlights: SITC 2024 Special EditionNovember 9th, 2024
- Year in Review: Non-Small Cell Lung CancerNovember 1st, 2024
- Join now to see all
Grant Support
- Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapyUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029
- Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2021–2026
